Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 431-440 of 1760 for

Edit search filters
  1. Phase II Venetoclax, Obinutuzumab And Bendamustine In High Tumor Burden Follicular Lymphoma As Front Line Therapy

    Rochester, MN

  2. A Study Of Poziotinib In Patients With NSCLC With EGFR Or HER2 Exon 20 Insertion Mutation

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Individualized Treatment In Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based On EBV DNA

    Rochester, MN

  4. Vaccine Therapy In Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, Or Primary Peritoneal Cavity Cancer Following Surgery And Chemotherapy

    Rochester, MN

  5. A Study Of Androgen Annihilation In High-Risk Biochemically Relapsed Prostate Cancer

    Scottsdale/Phoenix, AZ

  6. A Study To Define Axl Expression Level In Skin Biopsy Specimens From Patients With Skin Cancer In Relation To Chronic Lymphocytic Leukemia

    Rochester, MN

  7. A Clinical And Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma

  8. A Study In Subjects With Relapsed And Refractory Multiple Myeloma Receiving Carfilzomib In Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing (ARROW)

    Scottsdale/Phoenix, AZ

  9. Thoracotomy Versus Thoracoscopic Management Of Pulmonary Metastases In Patients With Osteosarcoma

    Rochester, MN

  10. IMC-F106C Regimen Versus Nivolumab Regimens In Previously Untreated Advanced Melanoma (PRISM-MEL-301)

    Jacksonville, FL

.

Mayo Clinic Footer